Free Trial

Oxford Nanopore Technologies (ONT) Share Price, News & Analysis

GBX 110.10
+5.60 (+5.36%)
(As of 07/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
2.17 million shs
Average Volume
1.19 million shs
Market Capitalization
£949.71 million
P/E Ratio
Dividend Yield
Price Target
GBX 276.75

Oxford Nanopore Technologies MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
151.4% Upside
GBX 276.75 Price Target
Short Interest
Dividend Strength
News Sentiment
1.31mentions of Oxford Nanopore Technologies in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
£115.13 M Sold Last Quarter
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.73 out of 5 stars

ONT stock logo

About Oxford Nanopore Technologies Stock (LON:ONT)

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific. The company operates in Life Science Research Tools and Covid Testing segments. It offers MinION, a portable device for DNA and RNA; GridION, a flexible and self-contained benchtop nanopore sequencer to run and analyse up to five MinION or Flongle flow cells; MinION Mk 1C, a nano pore-based sequencer with analysis software and connectivity for self-contained and portable sequencing; Flongle, an adapter for MinION or GridION that enables DNA sequencing or cDNA sequencing on smaller and single-use flow cells; and PromethION 2 Solo, a sequencer for two PromethION flow cells. The company also provides PromethION 2, a self-contained benchtop nanopore sequencer; PromethION 24, which provides single or multiple users with access to terabases of sequencing data; PromethION 48, a sequencing device with high-output flow cells; VolTRAX, an automated library prep for nanopore analyses; and Q-Line, a sequencing for applied applications, as well as products for SAR-Cov-2 testing. Its platform enables its customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science. The company was formerly known as Oxford NanoLabs Limited and changed its name to Oxford Nanopore Technologies plc in May 2008. Oxford Nanopore Technologies plc was incorporated in 2005 and is headquartered in Oxford, the United Kingdom.

ONT Stock Price History

ONT Stock News Headlines

I’m giving you the name of this investment for free
I want to help you achieve that right by accessing a new business model in America that has been unlocked by a billionaire who may end up sitting in Trump’s cabinet.
I’m giving you the name of this investment for free
I want to help you achieve that right by accessing a new business model in America that has been unlocked by a billionaire who may end up sitting in Trump’s cabinet.
Oxford Nanopore Technologies PLC ADR
Oxford Nanopore Technologies PLC ONTTF
See More Headlines
Receive ONT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford Nanopore Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Year Founded

Price Target and Rating

Average Stock Price Target
GBX 276.75
High Stock Price Target
GBX 355
Low Stock Price Target
GBX 210
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
5 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
£169.67 million
Cash Flow
GBX 27.25 per share
Book Value
GBX 75 per share


Free Float
Market Cap
£949.71 million
Not Optionable
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Gurdial Singh Sanghera (Age 63)
    Co-Founder, CEO & Non-Executive Director
    Comp: $1.59M
  • Mr. Timothy Cowper (Age 59)
    COO & Director
    Comp: $894.98k
  • Dr. James Spike Willcocks
    Chief Strategy Officer & Director
  • Prof. Hagan Bayley Ph.D.
    Co-Founder & Member of Technical Advisory Board
  • Mr. Nicholas Patrick Keher (Age 42)
    CFO & Director
  • Mr. Jordan Herman
    Senior VP & General Counsel
  • Mr. John Schoellerman
    Senior Vice President of Corporate & Business Development
  • Mr. Richard Compton
    Senior Vice President of Sales & Commercial Operations
  • Ms. Sara Agee Le
    Vice President of Global Marketing
  • Ms. Sarah Lapworth
    Senior Vice President of Global Human Resources

ONT Stock Analysis - Frequently Asked Questions

How have ONT shares performed this year?

Oxford Nanopore Technologies' stock was trading at GBX 208.20 at the start of the year. Since then, ONT shares have decreased by 47.1% and is now trading at GBX 110.10.
View the best growth stocks for 2024 here

How do I buy shares of Oxford Nanopore Technologies?

Shares of ONT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:ONT) was last updated on 7/17/2024 by Staff

From Our Partners